Literature DB >> 15314682

Immune recognition of self in immunity against cancer.

Alan N Houghton1, José A Guevara-Patiño.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15314682      PMCID： PMC503781          DOI： 10.1172/JCI22685

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  20 in total

Review 1.  Immunity against cancer: lessons learned from melanoma.

Authors:  A N Houghton; J S Gold; N E Blachere
Journal:  Curr Opin Immunol       Date:  2001-04       Impact factor: 7.486

Review 2.  Rules for making human tumor cells.

Authors:  William C Hahn; Robert A Weinberg
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

3.  Immunological recognition of self.

Authors:  F M BURNET
Journal:  Science       Date:  1961-02-03       Impact factor: 47.728

4.  Immunity to methylcholanthrene-induced sarcomas.

Authors:  R T PREHN; J M MAIN
Journal:  J Natl Cancer Inst       Date:  1957-06       Impact factor: 13.506

5.  A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen.

Authors:  Jason S Gold; Cristina R Ferrone; Jose A Guevara-Patiño; William G Hawkins; Ruben Dyall; Manuel E Engelhorn; Jedd D Wolchok; Jonathan J Lewis; Alan N Houghton
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

6.  Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance.

Authors:  Zhiya Yu; Marc R Theoret; Christopher E Touloukian; Deborah R Surman; Scott C Garman; Lionel Feigenbaum; Tiffany K Baxter; Brian M Baker; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 7.  Rituximab: expanding role in therapy for lymphomas and autoimmune diseases.

Authors:  William Rastetter; Arturo Molina; Christine A White
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

8.  Coupling and uncoupling of tumor immunity and autoimmunity.

Authors:  W B Bowne; R Srinivasan; J D Wolchok; W G Hawkins; N E Blachere; R Dyall; J J Lewis; A N Houghton
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

9.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

10.  Heteroclitic immunization induces tumor immunity.

Authors:  R Dyall; W B Bowne; L W Weber; J LeMaoult; P Szabo; Y Moroi; G Piskun; J J Lewis; A N Houghton; J Nikolić-Zugić
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307
View more
  53 in total

Review 1.  Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression.

Authors:  Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2010-07       Impact factor: 4.388

2.  The roles of antigen-specificity, responsiveness to transforming growth factor-β and antigen-presenting cell subsets in tumour-induced expansion of regulatory T cells.

Authors:  David Coe; Caroline Addey; Matthew White; Elizabeth Simpson; Julian Dyson; Jian-Guo Chai
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

3.  TRAIL/DR5 plays a critical role in NK cell-mediated negative regulation of dendritic cell cross-priming of T cells.

Authors:  Mitsuhiro Iyori; Tong Zhang; Haddon Pantel; Bethany A Gagne; Charles L Sentman
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

4.  Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resection.

Authors:  Emily C Bellavance; Frederick J Kohlhapp; Andrew Zloza; Jeremy A O'Sullivan; James McCracken; Michael C Jagoda; Andrew T Lacek; Mitchell C Posner; Jose A Guevara-Patino
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

5.  Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma.

Authors:  Jack C F Liao; Polly Gregor; Jedd D Wolchok; Francesca Orlandi; Diane Craft; Carrie Leung; Alan N Houghton; Philip J Bergman
Journal:  Cancer Immun       Date:  2006-04-21

6.  Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.

Authors:  Güllü Görgün; Tobias A W Holderried; David Zahrieh; Donna Neuberg; John G Gribben
Journal:  J Clin Invest       Date:  2005-06-16       Impact factor: 14.808

Review 7.  TCR recognition of peptide/MHC class II complexes and superantigens.

Authors:  Eric J Sundberg; Lu Deng; Roy A Mariuzza
Journal:  Semin Immunol       Date:  2007-06-07       Impact factor: 11.130

8.  Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity.

Authors:  Natalia Lapteva; Melissa Aldrich; David Weksberg; Lisa Rollins; Tatiana Goltsova; Si-Yi Chen; Xue F Huang
Journal:  J Immunother       Date:  2009 Feb-Mar       Impact factor: 4.456

9.  Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.

Authors:  Adam D Cohen; Adi Diab; Miguel-Angel Perales; Jedd D Wolchok; Gabrielle Rizzuto; Taha Merghoub; Deonka Huggins; Cailian Liu; Mary Jo Turk; Nicholas P Restifo; Shimon Sakaguchi; Alan N Houghton
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

10.  Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy.

Authors:  Victoria M Velazquez; David G Bowen; Christopher M Walker
Journal:  Blood       Date:  2008-06-19       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.